BTIG Maintains Buy on Orchestra BioMed Hldgs, Raises Price Target to $12

Benzinga · 1d ago
BTIG analyst Marie Thibault maintains Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy and raises the price target from $10 to $12.